In our latest discussion, Albert Bekfi, Head of Global Pharmacovigilance Operations at Biomapas, is joined by Theo Giannou and Wee Chuan Lau from Bloom Agents, a regional pharmacovigilance service provider with over 30 years’ experience across Asia-Pacific (APAC).
They share timely insights on the evolving PV landscape in APAC, including:
- Navigating cultural diversity across the region
- Digital transformation and tightened safety reporting
- China’s 2024 CBDT rules and implications for cross-border ICSR transfers
- Inspection trends across Japan, Australia, China, Southeast Asia and Malaysia
- Local risk-management strategies and country-specific RMP adaptations
- Best practices for PV outsourcing, distributor delegation and vendor audits
